Evidence map›Paper›PMID 30872636›Full record

ArticleScientific reports2019

Disruption of CUL3-mediated ubiquitination causes proximal tubule injury and kidney fibrosis.

Turgay Saritas, Catherina A Cuevas, Mohammed Z Ferdaus, Christoph Kuppe, Rafael Kramann, Marcus J Moeller, Jürgen Floege, Jeffrey D Singer, James A McCormick

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Renal TRPM6 but not Kv1.1 is required for magnesium homeostasis in mice.American journal of physiology. Renal physiology · 2026
    Article
  3. Article
  4. Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Review
  7. Familial Hyperkalemic Hypertension.Comprehensive Physiology · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. NovelHypertension (Dallas, Tex. : 1979) · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Turgay SaritasDivision of Nephrology and Hypertension, Oregon Health and Science University, Portland, Oregon, USA. tsaritas@ukaachen.de.ORCID 0000-0002-6691-9218
Catherina A CuevasDivision of Nephrology and Hypertension, Oregon Health and Science University, Portland, Oregon, USA.
Mohammed Z FerdausDivision of Nephrology and Hypertension, Oregon Health and Science University, Portland, Oregon, USA.
Christoph KuppeDivision of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.
Rafael KramannDivision of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.
Marcus J MoellerDivision of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.
Jürgen FloegeDivision of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.
Jeffrey D SingerDepartment of Biology, Portland State University, Portland, Oregon, USA.
James A McCormickDivision of Nephrology and Hypertension, Oregon Health and Science University, Portland, Oregon, USA. mccormij@ohsu.edu.
Oregon Health & Science University · USRWTH Aachen University · DEPortland State University · US

Funding

WNK Kinase Regulation of Thiazide-sensitive NaCl TransportR01DK051496 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI David Hoadley Ellison, CHAO-LING YANG · 1998 to 2026
$8.4M
Regulation of sodium transport and blood pressure by SPAK/OSR1 kinasesR01DK098141 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI JAMES A MCCORMICK, Ujwal Shinde · 2014 to 2026
$4.2M
American Heart Association-American Stroke Association 17POST33670206NIDDK NIH HHS R01 DK051496NIDDK NIH HHS R01 DK098141
6 · The paper itself

Abstract

Cullin 3 (CUL3) is part of the ubiquitin proteasomal system and controls several cellular processes critical for normal organ function including the cell cycle, and Keap1/Nrf2 signaling. Kidney tubule-specific Cul3 disruption causes tubulointerstitial fibrosis, but little is known about the mechanisms. Therefore, we tested the hypothesis that dysregulation of the cell cycle and Keap1/Nrf2 pathway play a role in initiating the kidney injury upon Cul3 disruption. Cul3 deletion increased expression of cyclin E and p21, associated with uncontrolled proliferation, DNA damage, and apoptosis, all of which preceded proximal tubule injury. The cdk2-cyclin E inhibitor roscovitine did not prevent the effects of Cul3 deletion, but instead exacerbated the kidney injury. Injury occurred despite accumulation and activation of CUL3 substrate Keap1/Nrf2, proposed to be protective in kidney injury. Cul3 disruption led to progressive interstitial inflammation, functionally relevant renal fibrosis and death. Finally, we observed reduced CUL3 expression in several AKI and CKD mouse models and in fibrotic human kidney tissue. These data establish CUL3 knockout mice as a novel genetic CKD model in which dysregulation of the cell cycle may play a primary role in initiating tubule injury, and that CUL3 dysregulation could contribute to acute and fibrotic kidney disease.

Indexed as

Gene DeletionAnimalsBiomarkersCell LineCell ProliferationCullin ProteinsDisease Models, AnimalDNA DamageFibrosisFluorescent Antibody TechniqueGenetic Association StudiesGenetic Predisposition to DiseaseImmunohistochemistryKelch-Like ECH-Associated Protein 1Kidney DiseasesKidney Tubules, ProximalBiomarkersCul3 protein, mouseCullin ProteinsKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2

Identifiers

PMID30872636
PMCPMC6418206
OpenAlexW2920978480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.